Clinical trials
Recruiting Phase 3 Hypercholesterolemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Novartis Pharmaceuticals | 2 |
| A. Menarini International Licensing S.A. | 1 |
| Baylor Research Institute | 1 |
| Hasten Biopharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 7 |
| Dyslipidemias | 3 |
| Hyperlipoproteinemia Type II | 3 |
| Aortic Valve Stenosis | 2 |
| Cardiovascular Diseases | 2 |
| Heart Failure | 2 |
| Hyperlipidemias | 2 |
| Homozygous Familial Hypercholesterolemia | 1 |
| Metabolic Diseases | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.